Clinical Trials
Trial Name | Title | Site Investigator | Principle Investigator | NBC Approval Number | Drap Approval Number | Sponsor | Goverment Identifier | Status |
---|---|---|---|---|---|---|---|---|
A Phase 3, randomized, double-blind, placebo-controlled study to evaluate the effect of Bi-26 (strain of Bifidobacterium longum B. infantis) supplementation versus placebo on weight gain in underweight infants | Dr. Mahmood Jamal | Dr. Ume Sughra | 4-87/NBC-896/23/1102 | 03-31/2023-CT (PS) | Bill & Melinda Gates Medical Research Institute | In Progress | ||
A Multi-center, Randomized, Blinded, Placebo-controlled, Phase 3 Clinical Study to Evaluate the Efficacy, Safety and Immunogenicity of SARS-CoV-2 Bivalent mRNA Vaccine (LVRNAO21) as Booster in participants Aged 18 Years and Older Who Completed Primary/i Booster Dose(s) of SARS-CoV-2 Vaccination | Dr. Mir Abdul Waheed | Dr. Muhammad Raza Shah | No.4-87/COVID-135/23/1292 | 03-35/ 2023- CT (PS) | AIM Vaccine Co., Ltd. LiveRNA Therapeutics Inc. Ningbo Rongan Biological Pharmaceutical Co. Ltd | NCT05812014 | In Progress | |
HIP fracture Accelerated surgical Treatment And Care track 2 (HIP ATTACK-2) Trial | Dr. Mustafa Javed Bhalli | Dr. Aamer Nabi Nur | 4-87/NBC-872/22/453 | McMaster University Canada | NCT04743765 | In Progress | ||
A Phase 3, multicenter, randomized, double-blind, 24- week study of the clinical and antiviral effect of S217622 compared with placebo in non-hospitalized participants with COVID-19 | Dr Sajjad Naseer | Dr. Faisal Mahmood | 4-87/COVID-122/22/672 | 03-25/ 2023-CT (PS) | Shionogi Inc. National Institute of Allergy and Infectious Diseases (NIAID) USA | NCT05305547 | In Progress | |
Clinical Study to Compare Efficacy and Safety of AVT06 and EU-Eylea (ALVOEYE) | Dr. Jahanzeb Durrani | Dr. M.A. Rehman Siddiqui | 4-87/NBC-855/22/456 | 03-12/ 2022-CT (PS) | Alvotech Swiss AG | NCT05155293 | In Progress | |
Re-evaluating the Inhibition of Stress Erosions and against Gastrointestinal Bleeding in the critically ill (REVISE) | Dr. Mir Abdul Waheed | Dr. Mir Abdul Waheed | 4-87/NBC-730/22/1814 | McMaster University Canada | NCT03374800 | In Progress |
Regulatory approvals for a clinical research framework
DRAP
Maroof International Hospital Clinical trial unit is DRAP approved site for conducting clinical trials. Application guidelines for the conduct of clinical trials and required forms are available on the DRAP website.
NATIONAL BIOETHICS COMMITTEE
National Bioethics Committee is a notified body on bioethics working under the Ministry of National Health Services, Regulation and coordination. All applications for authorization of the conduction of clinical trials are required to seek prior approval from the National Bioethical Committee under Rules 9 of Bio-Study Rules, 2017. Ethical clearance of research projects through NBC Pakistan form are available on the following link:
IRB
Maroof’s IRB is registered in the Office of Human Research Protection Database, United States Department for Health & Human Services.
-
IORGNumber:IORG0011525
-
FWA Number:FWA00032840
The status of IRB can be searched through the following link:
Members Institutional Review Committee at Maroof International Hospital
Name | Speciality |
---|---|
Dr. Gulafsahan Hafeez | Gynaecologist |
Dr. Usman Aftab | Gastroenterologist |
Dr. Omer Mufti | Cardiologist |
Dr. Aliya Hameed baber | Consultant Geriatrics |
Dr. Mustafa Javed bhalli | Consultant Orthopaedics |
Mr. Bilal Shadani | Psycho Therapist |
Clinical Research Certification
- Good Clinical Practices Nida Training Certification https://gcp.nidatraining.org/
- Introduction to the Principles and Practice of Clinical Research https://ocr.od.nih.gov/courses/ippcrRegistration.html